Skip to content

Navigating the mental health impact of GLP-1s, with Rachel Goldman, PhD

Speaking of Psychology

Hosted by Kim Mills

37m
Transcript

Original podcast

About this episode

Over the past several years, the rise of GLP-1 drugs such as Ozempic and Wegovy has changed the conversation around weight and obesity in the U. S. Rachel Goldman, PhD, talks about how GLP-1s work; the effects they can have on mental health; what questions to ask if you’re considering trying these medications; how weight loss can shift people's relationships with their family, friends and partners; and why there’s still stigma around the use of GLP-1s and how patients can navigate that. Find Dr. Rachel's new book at When Life Happens: The Mindset Shift You Need to Manage Stress, Build Confidence, and Break Free. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

0:00
37:21

6,337 words · 7 speakers

Speaker names marked are inferred from speaking time and the show’s known hosts — they are not voice-verified.

Page updated · transcript and summary are machine-generated